Alternative splicing is an important mechanism behind KAI1 loss of function in breast cancer patients from Saudi

Haitham Kussaibi1, Khaled R Alkharsah2,3, Dalal Altamimi4

  • 1Department of Pathology, College of Medicine, Imam Abdulrahman Bin Faisal University (IAU), Dammam, Saudi Arabia. hkussaibi@iau.edu.sa.

Abstract

Insights

Alternative splicing causes loss of KAI1 (CD82) function in breast cancer, linked to advanced stages and poor prognosis. This study identified truncated-KAI1 in 22% of samples, correlating with metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • KAI1 (CD82) is a metastasis suppressor gene frequently downregulated in breast cancer.
  • Loss of KAI1 function is associated with poor prognosis in various solid tumors.
  • The precise mechanisms behind KAI1 downregulation remain complex and require further investigation.

Purpose of the Study:

  • To investigate alternative splicing as a mechanism for KAI1 loss of function in breast cancer patients.
  • To analyze KAI1 expression patterns in breast cancer tissues from Saudi Arabia.

Main Methods:

  • Immunohistochemistry (IHC) was used to assess KAI1 expression in FFPE breast cancer tissues.
  • Two antibodies, TS82B (extracellular domain) and EPR4112 (C-terminal domain), were employed to detect full-length and truncated KAI1.
  • Expression levels were correlated with clinical parameters, including cancer stage and lymph node metastasis.

Main Results:

  • 67% of 90 breast cancer samples exhibited loss of KAI1 expression.
  • Full-length KAI1 was detected in 33% of samples (TS82B antibody).
  • Truncated-KAI1 (detected by EPR4112 antibody) was found in 22% of samples, significantly correlating with advanced cancer stage and lymph node metastasis (P=0.008).

Conclusions:

  • Alternative splicing is a significant mechanism contributing to KAI1 loss of function in breast cancer.
  • The presence of truncated-KAI1 is associated with advanced disease stage and suggests a poor prognosis.
  • These findings highlight the clinical relevance of alternative splicing in breast cancer progression.

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.2K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.1K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.6K